Carbatrol, Carnexiv, Equetro, Tegretol, Tegretol-xr (carbamazepine) is a small molecule pharmaceutical. Carbamazepine was first approved as Carbatrol on 1982-01-01. It is used to treat bipolar disorder, complex partial epilepsy, mood disorders, post-traumatic stress disorders, and psychotic disorders amongst others in the USA. It is known to target frizzled-8. Tegretol's patents are valid until 2033-02-27 (FDA).
|Trade Name||Carbatrol, Carnexiv, Equetro, Tegretol, Tegretol-xr|
|Indication||bipolar disorder, complex partial epilepsy, mood disorders, post-traumatic stress disorders, psychotic disorders, restless legs syndrome, schizophrenia, substance withdrawal syndrome, tonic-clonic epilepsy, trigeminal neuralgia|
|Drug Class||Tricyclic compounds|